Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Biomed Pharmacother. 2016 Dec 29;87:58–72. doi: 10.1016/j.biopha.2016.12.083

Table 8.

In vivo imaging studies BBN derivatives radiolabeled with 18F, 111In and 86Y.

Radioisotope Peptide Linker Animal Model Reference
111In RM2-RGD DOTA PC-3 tumor-bearing SCID mice [93]
[Lys3, Tyr4]Bn(2–14) DTPA PC-3 tumor-bearing SCID mice [92]
18F BBN NOTA-4,7-lanthionine-BBN and NOTA-2,6-lanthionine-BBN PC-3 tumor-bearing athymic nude mice [96]
[Lys3]BBN and Aca-BBN(7–14) SFB PC-3 and DU-145 tumor-bearing athymic nude mice [97]
BBN(7–14)-RGD SFB PC-3 and DU-145 tumor-bearing athymic nude mice [98]
86Y MP2346 DOTA PC-3 tumor-bearing athymic mice and AR42J tumor-bearing rats [101]